StockWatch
·

Indiabulls Housing Finance Ltd

BSE: 535789

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
1.8K
+17.0%-14.1%
Expenditure
1.3K
+7.8%-22.2%
Net Profit
341.96
+51.6%+24.1%
OPM %
95.46%
-4.54pp+17.56pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-10.1K-5.8K-1.4K2.9K7.3KQ1 FY19Q2 FY19Q3 FY19Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Sammaan Capital: a ₹906 Cr promoter infusion lands at ₹139 a share — above where the stock trades today

warrant conversion · promoter stake · capital infusion

Research16 Nov 20265 minFinancial Services

Sammaan Capital Q2 FY27: Flat Consolidated PAT Hides ~68% Adjusted Profit Decline

housing finance · nbfc · impairment write-back

ResultsQ2 FY2714 Nov 20263 minFinancial Services

Profitability Recovery on Test — Can Sammaan Deliver ₹1,400 Cr FY27 PAT?

NBFC · profitability recovery · asset quality

Result previewQ2 FY2713 Nov 20263 minFinancial Services
Latest
Board Meeting3d ago, 12:00 pm

Sammaan Capital Q2 FY27: Flat Consolidated PAT Hides ~68% Adjusted Profit Decline

Sammaan Capital (formerly Indiabulls Housing Finance) reported consolidated PAT of ₹312.34 Cr for Q2 FY27, up just 1.3% YoY from ₹308.47 Cr and up 28.4% QoQ from ₹243.30 Cr, even as consolidated revenue from operations fell 17.8% YoY to ₹1,849.97 Cr (from ₹2,250.60 Cr) while rising 12.0% QoQ. The YoY PAT stability is misleading: stripping out the swing in the impairment line, pre-tax profit from core operations would have fallen roughly 68% YoY (an estimated ₹207.91 Cr versus ₹654.06 Cr a year ago, after tax ~₹152.9 Cr versus ~₹474.7 Cr) — this was a quarter kept in the black by a credit-cost reversal, not operating improvement. Consolidated net profit margin expanded to 16.9% of total income from 13.65% YoY and 14.46% QoQ, but the expansion traces entirely to 'impairment on financial instruments (net of recoveries/written back)' swinging to a ₹216.66 Cr credit this quarter from a ₹229.03 Cr charge in Q2 FY26 — a ₹445.69 Cr favorable swing that offset the topline decline. That topline decline was itself driven by 'net gain on derecognition of financial instruments' collapsing to ₹7.19 Cr from ₹468.81 Cr a year ago, as last year's Identified-Exposures reclassification/ARC-sale-linked income recognition normalized. Interest income also fell YoY, to ₹1,161.26 Cr from ₹1,449.02 Cr, despite the standalone loan book growing to ₹40,935.69 Cr (from ₹33,914.56 Cr at March-26) — a yield or asset-mix shift the filing does not itself explain. Against our pre-result preview (PAT ₹300–500 Cr, annualized ROA 1.6–1.8% expected), the quarter is in-line but at the bottom of the range: PAT of ₹312.34 Cr annualizes to an ROA of ~1.72% on ₹72,556.36 Cr of consolidated assets, inside the expected band, and disbursements (~₹6,000 Cr) and AUM (~₹59,000 Cr) both matched the company's own prior business update. But the preview framed this quarter as a test of whether PAT inflection was genuine rather than loan-growth- or accounting-driven — the impairment-reversal dependency argues it is not yet proven. Management gave no quarter-specific guidance in this filing or press release (only the procedural board-outcome letter was available); the Feb-2026 concall's targets — 4x–4.5x leverage by 2030, 100bps core-mortgage credit cost, ~270bps cost-of-funds reduction by March 2027 — are multi-year and not verifiable off a single quarter. Standalone PAT of ₹341.96 Cr (+24.1% YoY) diverges sharply from the consolidated +1.3% YoY print; the ₹29.62 Cr gap is fully explained by a net loss at the Group's nine subsidiaries and trust this quarter, so the core lending entity performed better than the group number suggests. Concurrently, Avenir Investment RSC sold a 6.94% stake even as it was separately allotted 8.68 Cr shares via warrant conversion, and the NCLT has fixed November 16, 2026 as the next hearing date for the Sammaan Finserve merger scheme. Going into Q3 FY27, the credit-cost line is the key swing factor to watch: two consecutive quarters of impairment write-backs (₹240.47 Cr in Q1 FY27, ₹216.66 Cr in Q2 FY27) have propped up reported profit, and any reversion to normalized provisioning would push the underlying ~68% adjusted YoY profit decline straight into the headline P&L.

14 Nov 2026, 12:00 pm

Corporate Events

Board MeetingSAMMAANCAP
2026
14Nov

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
30Sep

Board Meeting

The 21st Annual General Meeting of the shareholders of the C…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
10Sep

Board Meeting

A meeting of equity shareholders is scheduled to be held thr…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
7Sep

Board Meeting

The Board of Directors considered and approved the authoriza…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
13Aug

Board Meeting

The Board of Directors considered and approved the Unaudited…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
20Jul

Board Meeting

A meeting of the Securities Issuance and Investment Committe…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
10Jul

Board Meeting

The National Company Law Tribunal (NCLT) has allowed the com…

BSE Filing ↗
Board MeetingSAMMAANCAP
2026
7Apr

Board Meeting

Meeting to consider and approve the buyback of USD denominat…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
14Nov

Board Meeting

Consider and approve inter-alia Unaudited Standalone and Con…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
29Aug

Board Meeting

Convening 19th Annual General Meeting, Considering seeking s…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
24May

Board Meeting

consider and approve audited financial results, payment of d…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
15Mar

Board Meeting

Consider and approve raising of funds through issuance of de…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
28Jan

Board Meeting

consider and approve specific terms of the rights issue

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
24Jan

Board Meeting

rights issue of equity shares, deliberate upon various matte…

BSE Filing ↗
Board MeetingSAMMAANCAP
2024
17Jan

Board Meeting

Consider and approve raising funds

BSE Filing ↗
Board MeetingSAMMAANCAP
2023
14Nov

Board Meeting

Consideration and approval of unaudited financial results fo…

BSE Filing ↗